Crossmark

Clinical and economic consequences of treating patients with peripheral neuropathic pain with brand name or generic drugs in routine clinical practice: The effects of age and sex

Crossref DOI link: https://doi.org/10.1016/j.nrleng.2016.03.008

Published Print: 2018-04

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Navarro-Artieda, R.

Rejas-Gutiérrez, J.

Pérez-Paramo, M.

Sicras-Mainar, A.
License Information

Text and Data Mining valid from 2018-04-01

Version of Record valid from 2018-02-14
More Information

This article is maintained by: Elsevier

Article Title: Clinical and economic consequences of treating patients with peripheral neuropathic pain with brand name or generic drugs in routine clinical practice: The effects of age and sex

Journal Title: Neurología (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.nrleng.2016.03.008

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.nrl.2016.03.012

Content Type: article

Copyright: © 2016 Sociedad Española de Neurología. Published by Elsevier España, S.L.U.

Document is current

Any future updates will be listed below